Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Respiratory Cell and Molecular Biology

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1165/rcmb.2012-0201OCPMID 23258233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis

  2012cited by this paper
• Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

  2011cited by this paper
• Bone morphogenetic protein signalling in airway epithelial cells during regeneration.

  2011cited by this paper
• Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening

  2011cited by this paper
• Anti-infectives: can cellular screening deliver?

  2011cited by this paper
• Identification of a Molecular Activator for Insulin Receptor with Potent Anti-diabetic Effects*

  2011cited by this paper
• The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

  2011cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

  2011cited by this paper
• Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents

  2010cited by this paper
• Pirfenidone in idiopathic pulmonary fibrosis

  2010cited by this paper
• Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.

  2009cited by this paper
• Identification of chemical compounds that induce HIF-1alpha activity.

  2009cited by this paper
• Pirfenidone in idiopathic pulmonary fibrosis

  2009cited by this paper
• Small Molecule Activation of Adaptive Gene Expression

  2008cited by this paper
• The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

  2008cited by this paper
• Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.

  2008cited by this paper
• Natural‐Product‐Like Spiroketals and Fused Bicyclic Acetals as Potential Therapeutic Agents for B‐Cell Chronic Lymphocytic Leukaemia

  2008cited by this paper
• Chemically Induced Accumulation of GAGs Delays PrPSc Clearance but Prolongs Prion Disease Incubation Time

  2008cited by this paper
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• DNA binding of tilorone: 1H NMR and calorimetric studies of the intercalation.

  2007cited by this paper
• Pharmacokinetics of a synthetic interferon inducer amixin in mice.

  2007cited by this paper
• Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.

  2006cited by this paper
• Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats

  2006cited by this paper
• Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.

  2006cited by this paper
• OROPHARYNGEAL ASPIRATION OF A SILICA SUSPENSION PRODUCES A SUPERIOR MODEL OF SILICOSIS IN THE MOUSE WHEN COMPARED TO INTRATRACHEAL INSTILLATION

  2006cited by this paper
• An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct.

  2006cited by this paper
• Idiopathic pulmonary fibrosis: natural history and prognosis.

  2006cited by this paper
• Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review).

  2006cited by this paper
• Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

  2005cited by this paper
• Pharmacokinetics of amixin after repeated peroral administration to mice

  2005cited by this paper
• Interferon gamma-1b as Therapy for Idiopathic Pulmonary Fibrosis

  2004cited by this paper
• A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

  2004cited by this paper
• Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7).

  2004cited by this paper
• Impact of Basic Research on Tomorrow's MedicineThe Role of Transforming Growth Factor β in Lung Development and Disease

  2004cited by this paper
• Epithelial-mesenchymal interactions in the developing lung.

  2004cited by this paper
• Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins

  2004cited by this paper
• Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.

  2002cited by this paper
• Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

  2002cited by this paper
• Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease.

  2002cited by this paper
• Russian Experience in Screening, Analysis, and Clinical Application of Novel Interferon Inducers

  2001cited by this paper
• Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.

  2001cited by this paper
• A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998cited by this paper
• Signal transduction by bone morphogenetic proteins.

  1998cited by this paper
• The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.

  1998cited by this paper
• Tilorone-induced lysosomal lesions: the bisbasic character of the drug is essential for its high potency to cause storage of sulphated glycosaminoglycans.

  1996cited by this paper
• A simplified method for the analysis of hydroxyproline in biological tissues.

  1996cited by this paper
• Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression.

  1995cited by this paper
• Keratopathy after oral administration of tilorone hydrochloride.

  1980cited by this paper
• The Anti-inflammatory Actions of Tilorone Hydrochloride 1

  1975cited by this paper
• Bis‐deae‐fluorenone: A specific inhibitor of DNA polymerases from RNA tumor viruses

  1972cited by this paper
• Tilorone Hydrochloride: Mode of Action

  1970cited by this paper
• Tilorone Hydrochloride: An Orally Active Antiviral Agent

  1970cited by this paper

• Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling.

  2025cites this paper
• Tilorone increases glucose uptake in vivo and in skeletal muscle cells by enhancing Akt2/AS160 signaling and glucose transporter levels

  2023influential citation
• Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies

  2022cites this paper
• Self-Assembling Injectable Hydrogel for Controlled Drug Delivery of Antimuscular Atrophy Drug Tilorone

  2022cites this paper
• Biopolymers/Ceramic-Based Nanocomposite Scaffolds for Drug Delivery in Bone Tissue Engineering

  2021cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro [version 1; peer review: 2 approved]

  2021cites this paper
• Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart

  2021influential citation
• Tumours block protective muscle and nerve signals to cause cachexia

  2021cites this paper
• Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia

  2021cites this paper
• Opposing Roles of BMP and TGF-β Signaling Pathways in Pancreatitis: Mechanisms and Therapeutic Implication

  2019cites this paper
• Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

  2018cites this paper
• BMP7 regulates lung fibroblast proliferation in newborn rats with bronchopulmonary dysplasia

  2018cites this paper
• Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica‐induced lung fibrosis in mice

  2018influential citation
• Local delivery of strontium ranelate promotes regeneration of critical size bone defects filled with collagen sponge.

  2018cites this paper
• Unanswered Questions Regarding Sex and BMP/TGF-β Signaling

  2018cites this paper
• INHALABLE ANTIFIBROTIC COMPOUNDS

  2018cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro (version 1; referees: 2 approved)

  2017cites this paper
• Novel Anti-fibrotic Therapies

  2017cites this paper
• BMP Signaling in Articular Cartilage Repair and Regeneration: Potential Therapeutic Opportunity for Osteoarthritis

  2017cites this paper
• Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection

  2017cites this paper
• Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine

  2016cites this paper
• Increased expression of bone morphogenetic protein-7 and its related pathway provides an anti-fibrotic effect on silica induced fibrosis in vitro

  2015cites this paper
• Dual-controlled release system of drugs for bone regeneration.

  2015cites this paper
• BMP signalling: agony and antagony in the family.

  2015cites this paper
• Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis

  2015cites this paper
• Machine learning models identify molecules active against the Ebola virus in vitro

  2015cites this paper
• Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.

  2015cites this paper
• An Effective Synthesis Method for Tilorone Dihydrochloride with Obvious IFN-α Inducing Activity

  2015cites this paper
• Gremlin1 and chronic pancreatitis: a new clinical target and biomarker?

  2015cites this paper
• Bone morphogenetic proteins and their antagonists: current and emerging clinical uses

  2014cites this paper
• Small-molecule based musculoskeletal regenerative engineering.

  2014cites this paper
• Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice

  2014cites this paper
• Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models

  2014cites this paper
• Follistatin Is Induced by Ionizing Radiation and Potentially Predictive of Radiosensitivity in Radiation-Induced Fibrosis Patient Derived Fibroblasts

  2013cites this paper